Class / Patent application number | Description | Number of patent applications / Date published |
546269100 | Oxadiazoles (including hydrogenated) | 6 |
20100210845 | PROCESS FOR THE PREPARATION OF 4-(BENZIMIDAZOLYLMETHYLAMINO)-BENZAMIDES AND THE SALTS THEREOF - The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that
| 08-19-2010 |
20140155614 | PHARMACEUTICAL INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF - The present invention relates to a process for the preparation of dabigatran etexilate of the formula | 06-05-2014 |
546269400 | Oxadiazole ring bonded directly to the six-membered hetero ring | 4 |
20110112301 | CRYSTAL FORMS OF 5-[3-(2,5-DICHLORO-4, 6-DIMETHYL-1-OXY-PYRIDINE-3-YL)[1,2,4] OXADIAZOL-5-YL]-3-NITROBENZENE-1,2-DIOL - This invention relates to novel polymorphs of (HO) | 05-12-2011 |
20120232277 | PROCESS FOR THE PREPARATION OF 1,2,4-OXADIAZOL-3-YL DERIVATIVES OF CARBOXYLIC ACID - The present invention discloses processes for the preparation and isolation of [1,2,4]oxadiazo-3-yl derivatives of carboxylic acids. The derivatives are useful in the treatment of inflammatory diseases and conditions. | 09-13-2012 |
20140051862 | 5-MEMBERED RING HETEROAROMATIC DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY - This invention provides new compounds having NPY Y5 antagonistic activity. The present inventors found that a compound of the formula (I): | 02-20-2014 |
20170233377 | HETEROCYCLIC COMPOUNDS AS NAV CHANNEL INHIBITORS AND USES THEREOF | 08-17-2017 |